Related Experiment Video
Updated: Jun 26, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Endothelium-derived relaxing factor is an endogenous vasodilator in man
Abstract:
Removal of venous endothelium in man leads to vasoconstriction and loss of dilator response to acetylcholine but not to glyceryl trinitrate. This pattern of responses can be accounted for by loss of endothelium-derived relaxing factor (EDRF), but not by loss of prostacyclin. This provides the first direct evidence for endothelium-dependent dilatation in man in vivo, and suggests that basal release of EDRF is a determinant of resting venous tone.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Vasodilators
Nitric Oxide Signaling Pathway
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Regulation of Angiogenesis and Blood Supply
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Vascular Spasm

